Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 40CNS 12Genitourinary 7Lymphoid 5Gastrointestinal 5Gynecologic 3Thoracic 2Dermatologic 2Breast 2Other solid neoplasm 1Other hematologic neoplasm 1Other 1Head & Neck 1

Conditions

Obesity 20Mucositis 19Constipation 13Neoplasms 11Opioid-Induced Constipation 9Pain 8Overweight 6Head and Neck Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Sexual Dysfunction, Physiological 4Bronchiolitis Obliterans Syndrome 4Xerostomia 3Stomatitis 3Radiation Injuries 3Polycystic Ovary Syndrome 3Endometrial Neoplasms 3Breast Neoplasms 3Sedentary Behavior 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Multiple Myeloma 2Glucose Intolerance 2Dyspnea 2Chemotherapy-induced Peripheral Neuropathy 2Venous Thromboembolism 1Urinary Incontinence 1Thyroid Diseases 1Stomach Ulcer 1Stomach Neoplasms 1

Interventions

glucarpidase 1Methotrexate 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Osteosarcoma × Other × Clear all
NCT02022358 2015-06-04

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

University College, London

Phase 2 Terminated
34 enrolled
OtherSarcoma

Osteosarcoma, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡